Rankings
▼
Calendar
CRON Q3 2020 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$981M
Q3 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11M
Gross Profit
-$2M
-13.5% margin
Operating Income
-$41M
-362.5% margin
Net Income
$69M
607.8% margin
EPS (Diluted)
$0.18
QoQ Revenue Growth
-15.3%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$36M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$154M
Stockholders' Equity
$1.8B
Cash & Equivalents
$1.1B
Revenue Segments
Cannabis Flower
$8M
70%
Cannabis Extracts
$3M
28%
Product and Service, Other
$257,000
2%
Geographic Segments
CANADA
$9M
81%
UNITED STATES
$2M
14%
Other Countries
$514,000
5%
← FY 2020
All Quarters
Q4 2020 →